4
Changes in Ownership
Evommune, Inc. Filed Acc 0002092017-26-000003
Options or other derivatives
- Chief Scientific Officer acquired 69,315 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Patel Jeegar Pravinkumar Chief Scientific Officer | 2026-04-16 | Grant or award · Employee Stock Option (Right to Buy) | +69,315 | 69,315 | D | ||
Loading xslF345X06/primarydocument.xml…